Discover
YDES
YD Bio Limited Ordinary Shares
2.73
1 x 2.56
1 x 2.80
bid
ask
+
0.23
8.98%
5 @ 04:00 PM
2.56 -0.17 (6.22%)
| Ytd | -77.60% | |
| 1y | -79.57% |
2.50
day range
2.75
1.70
52 week range
25.00
| Open | 2.54 | Prev Close | 2.50 | Low | 2.50 | High | 2.75 | Mkt Cap | 193.37M |
| Vol | 20.83K | Avg Vol | 133.69K | EPS | -0.12 | P/E | -22.75 | Forward P/E | N/A |
| Beta | 0.16 | Short Ratio | 0.77 | Inst. Own | 0.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.52 | 200-d Avg | 7.57 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Cerity Partners LLC | 32.41K | 429.06K | 0.05% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2025-09-29 | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 20.86K | 276.21K | 0.03% |